Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 11, 2020 at 06:14 pm EDT
Share
Universal Vision Biotechnology Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 483.991 million compared to TWD 358.714 million a year ago. Operating income was TWD 141.174 million compared to TWD 72.726 million a year ago. Net income was TWD 114.989 million compared to TWD 73.296 million a year ago. Basic earnings per share was TWD 1.51 compared to TWD 0.97 a year ago. Diluted earnings per share was TWD 1.51 compared to TWD 0.96 a year ago. For the half year, sales was TWD 878.788 million compared to TWD 669.748 million a year ago. Operating income was TWD 242.283 million compared to TWD 117.723 million a year ago. Net income was TWD 204.348 million compared to TWD 120.079 million a year ago. Basic earnings per share was TWD 2.68 compared to TWD 1.58 a year ago. Diluted earnings per share was TWD 2.68 compared to TWD 1.57 a year ago.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. 
